Genetic Technologies Limited
GNTLF
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.38% | 12.30% | 0.44% | -16.66% | -40.72% |
| Total Depreciation and Amortization | -37.41% | -39.17% | -41.07% | -32.68% | -23.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.45% | -26.63% | -9.24% | 203.68% | 1,274.01% |
| Change in Net Operating Assets | 167.46% | 167.46% | 167.46% | 46.59% | -335.05% |
| Cash from Operations | 25.15% | 12.07% | 2.88% | 3.41% | 3.09% |
| Capital Expenditure | 71.89% | 25.63% | -83.05% | -92.25% | -100.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.12% | 42.89% | -25.15% | 40.93% | 230.95% |
| Cash from Investing | 135.26% | 575.00% | 136.03% | 139.56% | 142.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -40.14% | -22.08% | -3.69% | 8.52% | 18.30% |
| Issuance of Common Stock | -63.54% | -63.81% | -64.07% | 35.93% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.13% | 94.69% | 99.26% | 0.15% | -8,728.85% |
| Cash from Financing | -56.48% | -55.06% | -53.55% | 54.95% | 1,427.08% |
| Foreign Exchange rate Adjustments | -134.38% | -135.73% | -136.76% | -66.63% | 196.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.45% | -89.39% | -72.90% | 36.40% | 86.18% |